Sumitomo Dainippon Pharma

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Data from AbbVie and Johnson & Johnson will fine-tune OpenFold3 in a confidentiality-preserving environment, powered by Apheris.

Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the appointment of Dr. Mikael Dolsten to its board of directors.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO says can "understand the concept of time and how you change, from cradle to grave.

News of more investment from the top chip manufacturer is exciting for Americans - but how about international competitors?

"For the past 10 years, we have been working on using AI to solve real-world problems," Daisuke Okanohara of Preferred Networks told CNBC's "Managing Asia."

The Tokyo-1 supercomputer - unveiled at the NVIDIA GTC AI conference this week - will be made available to Japan's pharma companies and startups in a bid to accelerate the adoption of AI ...

SoftBank has committed to spending $3 billion per year to use OpenAI's tech, according to a joint release released on Monday.